Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update
Go back to Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.98 +0.05 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $9.58 | |||
| Open | $2.86 | 52 Week Low | $2.34 | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $2.86 | EPS | $-0.34 | |||
| Volume | 429,870 | |||||
